Corient Private Wealth’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
7,792
+2,197
+39% +$326K ﹤0.01% 1571
2026
Q1
$521K Sell
5,595
-197
-3% -$17.4K ﹤0.01% 2008
2025
Q4
$466K Buy
5,792
+222
+4% +$18.6K ﹤0.01% 1901
2025
Q3
$544K Buy
+5,570
New +$449K ﹤0.01% 1753
2024
Q4
Sell
-2,842
Closed -$298K 2359
2024
Q3
$298K Sell
2,842
-3,952
-58% -$462K ﹤0.01% 2015
2024
Q2
$966K Buy
6,794
+4,453
+190% +$513K ﹤0.01% 1346
2024
Q1
$261K Buy
2,341
+622
+36% +$74.1K ﹤0.01% 1968
2023
Q4
$223K Sell
1,719
-6
-0.3% -$827 ﹤0.01% 2013
2023
Q3
$281K Sell
1,725
-5
-0.3% -$879 ﹤0.01% 1777
2023
Q2
$317K Sell
1,730
-1,668
-49% -$240K ﹤0.01% 1672
2023
Q1
$453K Buy
+3,398
New +$399K ﹤0.01% 1426

Other funds holding ACLS

Corient Private Wealth's ACLS Position: Q2 2026 in Review

Corient Private Wealth increased its Axcelis (ACLS) stake by 39% in Q2 2026, buying an estimated $326K and bringing the position to 7,792 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

Corient Private Wealth first reported a position in ACLS in Q1 2023 and has held it in 11 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Corient Private Wealth held 7,792 shares of Axcelis worth $1.48M as of Q2 2026.
  • Corient Private Wealth bought 2,197 Axcelis shares in Q2 2026, an estimated $326K.
  • Axcelis made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1571 holding.
  • Corient Private Wealth first reported a position in Axcelis in Q1 2023 and has held it in 11 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.